↓ Skip to main content

Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial

Overview of attention for article published in Frontiers in immunology, September 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
4 X users

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial
Published in
Frontiers in immunology, September 2023
DOI 10.3389/fimmu.2023.1241153
Pubmed ID
Authors

Jialei Hu, Yueyue Liu, Shuo Liu, Qun Shu, Xuenan Yang, Kai Chu, Yaping Qiao, Yaling Hu, Kaiqin Wang, Hongxing Pan

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 17%
Professor 1 8%
Student > Ph. D. Student 1 8%
Lecturer 1 8%
Other 1 8%
Other 0 0%
Unknown 6 50%
Readers by discipline Count As %
Nursing and Health Professions 3 25%
Pharmacology, Toxicology and Pharmaceutical Science 2 17%
Engineering 1 8%
Unknown 6 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 October 2023.
All research outputs
#16,294,636
of 26,180,352 outputs
Outputs from Frontiers in immunology
#15,952
of 32,860 outputs
Outputs of similar age
#170,407
of 361,638 outputs
Outputs of similar age from Frontiers in immunology
#413
of 1,226 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 32,860 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,638 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 1,226 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.